Giuliana La Rosa
Giuliana La Rosa has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Letizia Antonella Mauro
Department of Medical Surgical Sciences and Advanced Technologies “GF Ingrassia”, UOSD IPTRA (Pulmonary and Advanced Radiological Techniques Unit) University Hospital Policlinico “G. Rodolico-San Marco”, Catania, Italy
2 shared publications- Stefano Palmucci
UOSD IPTRA, Department of Medical Surgical Sciences and Advanced Technologies “GF Ingrassia”, University Hospital Policlinico “G. Rodolico-San Marco”, University of Catania, 95123 Catania, Italy
2 shared publications - Adele Valentini
Unità Operativa Radiologia Diagnostica per Immagini 1, Fondazione IRCCS Policlinico San Matteo, Viale Golgi, 19, 27100 Pavia, PV, Italy
1 shared publication - Adriana Ilardi
Department of Medical Surgical Sciences and Advanced Technologies “GF Ingrassia”, University of Catania, University Hospital Policlinico G. Rodolico-San Marco, Catania, Italy
1 shared publication Alessandra Sigona
Ambulatory Specialist “UOSD Radiologia Territoriale-Centro Amianto e Risonanza Magnetica Multidistrettuale” ASP 8 Siracusa, Siracusa, Italy
1 shared publication- Alessandro Libra
Department of Clinical and Experimental Medicine, Regional Referral Center for Rare Lung Diseases, Policlinico “G.Rodolico-San Marco”, University of Catania, 95123 Catania, Italy
1 shared publication
Latest Publications
- Open Access
- 20 September 2025
- Published by Springer Nature in Insights into Imaging
- Vol. 16 (1) , 1-14
A pictorial essay of thoracic wall diseases: multiple pathologies in the same anatomical site
Objectives: To describe diagnostic and radiological features of the main pathologies affecting the thoracic wall, providing a pictorial atlas based on several clinical cases extracted from our archive. Materials and methods: A wide variety of pathologies affect the tissues of the thoracic cage; these conditions are often encountered by radiologists during examinations performed for unrelated clinical questions. Modern imaging techniques enable the detection of these pathologies and allow definitive diagnoses to be achieved. Results: Pathological processes that involve the chest wall may be classified into: (1) congenital and developmental diseases: pectus excavatum, pectus carinatum, supernumerary rib syndrome, Poland syndrome, neurofibromatosis, osteogenesis imperfecta, mucopolysaccharidosis, Marfan syndrome; (2) infectious and inflammatory diseases—such as aspergillosis, tuberculosis, abscesses from pyogenic bacteria, Tietze’s syndrome; (3) bone injuries (traumatic and degenerative diseases): sternal, vertebral and costal fractures, degenerative disc and arthrosis pathology; (4) chest wall tumors—such as sarcomas, lymphomas, neurogenic tumors, lipoma. Conclusions: Thoracic wall pathologies include a wide spectrum of conditions, with some clinical implications that often require a correct nosological framing. Recognizing these pathologies is essential for radiologists so that they can make a correct description in the report and direct toward appropriate treatment if required. Critical relevance statement: Cage diseases are various and difficult to understand, so multimodality imaging plays a crucial role in achieving an efficient and final diagnosis. Key Points: Thoracic wall pathologies have different etiologies. Imaging represents a fundamental tool to clarify their extension, location, and nature. The prognosis of some of these diseases can be poor. Graphical
- 20 September 2025
- Published by Springer Nature in Insights into Imaging
- Vol. 16 (1) , 1-14
Open AccessA pictorial essay of thoracic wall diseases: multiple pathologies in the same anatomical site
Objectives: To describe diagnostic and radiological features of the main pathologies affecting the thoracic wall, providing a pictorial atlas based on several clinical cases extracted from our archive. Materials and methods: A wide variety of pathologies affect the tissues of the thoracic cage; these conditions are often encountered by radiologists during examinations performed for unrelated clinical questions. Modern imaging techniques enable the detection of these pathologies and allow definitive diagnoses to be achieved. Results: Pathological processes that involve the chest wall may be classified into: (1) congenital and developmental diseases: pectus excavatum, pectus carinatum, supernumerary rib syndrome, Poland syndrome, neurofibromatosis, osteogenesis imperfecta, mucopolysaccharidosis, Marfan syndrome; (2) infectious and inflammatory diseases—such as aspergillosis, tuberculosis, abscesses from pyogenic bacteria, Tietze’s syndrome; (3) bone injuries (traumatic and degenerative diseases): sternal, vertebral and costal fractures, degenerative disc and arthrosis pathology; (4) chest wall tumors—such as sarcomas, lymphomas, neurogenic tumors, lipoma. Conclusions: Thoracic wall pathologies include a wide spectrum of conditions, with some clinical implications that often require a correct nosological framing. Recognizing these pathologies is essential for radiologists so that they can make a correct description in the report and direct toward appropriate treatment if required. Critical relevance statement: Cage diseases are various and difficult to understand, so multimodality imaging plays a crucial role in achieving an efficient and final diagnosis. Key Points: Thoracic wall pathologies have different etiologies. Imaging represents a fundamental tool to clarify their extension, location, and nature. The prognosis of some of these diseases can be poor. Graphical
- Open Access
- 6 February 2024
- Published by Springer Nature in La radiologia medica
- Vol. 129 (3) , 411-419
Study rationale and design of the PEOPLHE trial
Purpose: Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20–40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth” (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities. Methods: PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50–75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support. Conclusion: The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems.
- 6 February 2024
- Published by Springer Nature in La radiologia medica
- Vol. 129 (3) , 411-419
Open AccessStudy rationale and design of the PEOPLHE trial
Purpose: Lung cancer screening (LCS) by low-dose computed tomography (LDCT) demonstrated a 20–40% reduction in lung cancer mortality. National stakeholders and international scientific societies are increasingly endorsing LCS programs, but translating their benefits into practice is rather challenging. The “Model for Optimized Implementation of Early Lung Cancer Detection: Prospective Evaluation Of Preventive Lung HEalth” (PEOPLHE) is an Italian multicentric LCS program aiming at testing LCS feasibility and implementation within the national healthcare system. PEOPLHE is intended to assess (i) strategies to optimize LCS workflow, (ii) radiological quality assurance, and (iii) the need for dedicated resources, including smoking cessation facilities. Methods: PEOPLHE aims to recruit 1.500 high-risk individuals across three tertiary general hospitals in three different Italian regions that provide comprehensive services to large populations to explore geographic, demographic, and socioeconomic diversities. Screening by LDCT will target current or former (quitting < 10 years) smokers (> 15 cigarettes/day for > 25 years, or > 10 cigarettes/day for > 30 years) aged 50–75 years. Lung nodules will be volumetric measured and classified by a modified PEOPLHE Lung-RADS 1.1 system. Current smokers will be offered smoking cessation support. Conclusion: The PEOPLHE program will provide information on strategies for screening enrollment and smoking cessation interventions; administrative, organizational, and radiological needs for performing a state-of-the-art LCS; collateral and incidental findings (both pulmonary and extrapulmonary), contributing to the LCS implementation within national healthcare systems.
- Open Access
- 10 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (2) , 369
The Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis
Background: We proposed the term “UIPAF” to define patients with Usual Interstitial Pneumonia (UIP) associated with only one domain of the classification called “Interstitial Pneumonia with Autoimmune Features” (IPAF). The objective of this study was to evaluate the clinical presentation and prognosis of UIPAF patients, compared with two cohorts, composed of IPAF and idiopathic pulmonary fibrosis (IPF) patients, respectively. Methods: The patients were enrolled as IPAF, UIPAF, or IPF based on clinical, serological, and radiological data and evaluated by a multidisciplinary team. Results: We enrolled 110 patients with IPF, 69 UIPAF, and 123 IPAF subjects. UIPAF patients were similar to IPAF regarding autoimmune features, except for the prevalence of Rheumatoid Factor in UIPAF and anti-SSA in IPAF. A similar proportion of the two cohorts progressed toward a specific autoimmune disease (SAD), with differences in the kind of SAD developed. The real-life management and prognosis of UIPAF patients proved to be almost identical to IPF. Conclusions: UIPAF shared with IPAF similar autoimmune features, suggesting the opportunity to be considered IPAF, excluding the morphological domain by the classification. However, the real-life management and prognosis of UIPAF are similar to IPF. These data suggest a possible modification in the therapeutic management of UIPAF.
- 10 January 2024
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 13 (2) , 369
Open AccessThe Pattern and Progression of “Usual” Interstitial Pneumonia with Autoimmune Features: Comparison with Patients with Classic Interstitial Pneumonia with Autoimmune Features and Idiopathic Pulmonary Fibrosis
Background: We proposed the term “UIPAF” to define patients with Usual Interstitial Pneumonia (UIP) associated with only one domain of the classification called “Interstitial Pneumonia with Autoimmune Features” (IPAF). The objective of this study was to evaluate the clinical presentation and prognosis of UIPAF patients, compared with two cohorts, composed of IPAF and idiopathic pulmonary fibrosis (IPF) patients, respectively. Methods: The patients were enrolled as IPAF, UIPAF, or IPF based on clinical, serological, and radiological data and evaluated by a multidisciplinary team. Results: We enrolled 110 patients with IPF, 69 UIPAF, and 123 IPAF subjects. UIPAF patients were similar to IPAF regarding autoimmune features, except for the prevalence of Rheumatoid Factor in UIPAF and anti-SSA in IPAF. A similar proportion of the two cohorts progressed toward a specific autoimmune disease (SAD), with differences in the kind of SAD developed. The real-life management and prognosis of UIPAF patients proved to be almost identical to IPF. Conclusions: UIPAF shared with IPAF similar autoimmune features, suggesting the opportunity to be considered IPAF, excluding the morphological domain by the classification. However, the real-life management and prognosis of UIPAF are similar to IPF. These data suggest a possible modification in the therapeutic management of UIPAF.
- Open Access
- 1 July 2022
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 41 (3) , 444-461
Vascular compression syndromes: a pictorial review
Vascular compression syndromes include a group of rare vascular changes due to extrinsic compression of veins or arteries by surrounding structures. These pathologies are often underestimated due to their rarity, clinicians’ poor level of knowledge, and the non-specificity of their symptoms. The best known are Eagle syndrome, thoracic outlet syndrome, nutcracker syndrome, May-Thurner syndrome, Dunbar syndrome, and popliteal entrapment syndrome. This work summarizes the main ultrasonographic characteristics, symptoms, and treatments of choice for these syndromes. Knowledge of these conditions’ characteristic signs is essential for the differential diagnosis. Failure to diagnose these rare diseases can expose patients to serious complications and risks to their health.
- 1 July 2022
- Published by Korean Society of Ultrasound in Medicine in Ultrasonography
- Vol. 41 (3) , 444-461
Open AccessVascular compression syndromes: a pictorial review
Vascular compression syndromes include a group of rare vascular changes due to extrinsic compression of veins or arteries by surrounding structures. These pathologies are often underestimated due to their rarity, clinicians’ poor level of knowledge, and the non-specificity of their symptoms. The best known are Eagle syndrome, thoracic outlet syndrome, nutcracker syndrome, May-Thurner syndrome, Dunbar syndrome, and popliteal entrapment syndrome. This work summarizes the main ultrasonographic characteristics, symptoms, and treatments of choice for these syndromes. Knowledge of these conditions’ characteristic signs is essential for the differential diagnosis. Failure to diagnose these rare diseases can expose patients to serious complications and risks to their health.